描述

Oligonucleotide synthesis is the chemical process by which nucleotides are specifically linked to form the desired sequenced product. The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence. 根据StrategyHelix, the global oligonucleotide synthesis market is expected to increase by US$ 4,683.6 期间百万 2022-2028, 复合年增长率为 9.7% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for oligonucleotide synthesis. The global oligonucleotide synthesis market is segmented on the basis of product, 应用, 最终用户, 和地区. 根据产品, the global oligonucleotide synthesis market is categorized into oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, 服务. The oligonucleotide drugs segment captured the largest share of the market in 2021. 根据应用, the global oligonucleotide synthesis market has been segmented into diagnostics, therapeutics, 研究. The research segment held the largest share of the global oligonucleotide synthesis market in 2021 预计在预测期内将持有其份额. 按最终用户, the global oligonucleotide synthesis market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes. 在 2021, the academic research institutes segment made up the largest share of revenue generated by the oligonucleotide synthesis market. 地理上, the global oligonucleotide synthesis market is segmented into North America, 亚太地区, 欧洲, 世界其他地区 (排). 在这些当中, North America was accounted for the highest revenue generator in 2021.

The global oligonucleotide synthesis market is highly competitive. The prominent players operating in the global oligonucleotide synthesis market include Agilent Technologies Inc., Biolegio BV, Biolytic Lab Performance Inc., CustomArray Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the oligonucleotide synthesis market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, 服务
应用: diagnostics, therapeutics, 研究
最终用户: 制药 & biotechnology companies, diagnostic laboratories, academic research institutes
地区: 北美, 亚太地区, 欧洲, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global oligonucleotide synthesis market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Oligonucleotide synthesis market overview
部分 3. 按产品划分的市场细分
– Oligonucleotide drugs
– Synthesized oligonucleotides
– Reagents
– 设备
– 服务
部分 4. 按应用划分的市场细分
– Diagnostics
– Therapeutics
– Research
部分 5. 按最终用户划分的市场细分
– 制药 & biotechnology companies
– Diagnostic laboratories
– Academic research institutes
部分 6. 按地区划分的市场细分
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (排)
部分 7. 重点企业
– Agilent Technologies, 公司.
– Biolegio BV
– Biolytic Lab Performance, 公司.
– CustomArray, 公司.
– Danaher Corporation
– Eurofins Scientific SE
– LGC Ltd.
– Merck KGaA
– Microsynth AG
– Thermo Fisher Scientific Inc.
关于StrategyHelix
免责声明